|
|
.
See Category: Diseases of the digestive system
See Header: Crohn's disease, unspecified, with complications
ICD-10 (CM) Code and Descriptor
|
K50.918 |
Crohn's disease, unspecified, with other complication
|
K50918 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 43.51%
|
20.49%
|
13.35%
|
6.83%
|
5.12%
|
3.35%
|
2.55%
|
1.31%
|
1.13%
|
0.58%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for K50.918*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
685
|
687
|
|
80053
|
COMPREHEN METABOLIC PANEL |
637
|
637
|
|
96365
|
THER/PROPH/DIAG IV INF INIT |
520
|
520
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
467
|
469
|
|
96413
|
CHEMO IV INFUSION 1 HR |
427
|
427
|
|
83735
|
ASSAY OF MAGNESIUM |
409
|
414
|
|
J1745
|
INFLIXIMAB NOT BIOSIMIL 10MG |
374
|
17,456
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
306
|
307
|
|
J7050
|
NORMAL SALINE SOLUTION INFUS |
304
|
373
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
286
|
417
|
|
96415
|
CHEMO IV INFUSION ADDL HR |
279
|
307
|
|
84100
|
ASSAY OF PHOSPHORUS |
274
|
275
|
|
86140
|
C-REACTIVE PROTEIN |
262
|
263
|
|
J3380
|
INJ VEDOLIZUMAB IV 1 MG |
241
|
72,600
|
|
96366
|
THER/PROPH/DIAG IV INF ADDON |
193
|
273
|
|
80048
|
METABOLIC PANEL TOTAL CA |
191
|
193
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
186
|
785
|
|
96361
|
HYDRATE IV INFUSION ADD-ON |
176
|
219
|
|
J1642
|
INJ HEPARIN SODIUM PER 10 U |
151
|
6,897
|
|
96360
|
HYDRATION IV INFUSION INIT |
143
|
145
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
K50.918 related to the following DRG Codes:
385-387
|
